ALLMedicine™ Dengue Center

Mar 18th, 2023 - Among the emerging and reemerging arboviral diseases, Zika, dengue and chikungunya deserve special attention due to their wide geographical distribution and clinical severity. The three arboviruses are transmitted by the same vector and can presen...

Mar 18th, 2023 - Neglected tropical diseases are a global public health problem. Although Brazil is largely responsible for their occurrence in Latin America, research funding on the subject does not meet the population's health needs. The present study analyzed t...

Mar 18th, 2023 - The rising cases of dengue amidst the prolonged monsoon in Pakistan: Challenges, efforts and recommendations.|2023|Khan HA,Malik UU,Yousuf J,Shahzad A,Ur Rehman M,|

Mar 18th, 2023 - Notes From the Field: First Evidence of Locally Acquired Dengue Virus Infection - Maricopa County, Arizona, November 2022.|2023|Kretschmer M,Collins J,Dale AP,Garrett B,Koski L,|

Mar 18th, 2023 - Early detection of Zika virus (ZIKV) transmission within geographic regions informs implementation of community mitigation measures such as vector reduction strategies, travel advisories, enhanced surveillance among pregnant women, and possible im...

Jun 14th, 2019 - Dengue and Zika viruses are closely related mosquitoborne flaviviruses with similar transmission cycles, distribution throughout the tropics and subtropics, and disease manifestations including fever, rash, myalgia, and arthralgia. For patients wi...

Nov 26th, 2010 - Dengue fever is a virus infection that is spread by the Aedes aegypti mosquito and can cause severe disease especially in children. Dengue fever is a major problem in tropical and sub-tropical regions of the world. We invited dengue experts from a...

Jul 4th, 2008 - There is a pressing need for guidelines focused on the clinical evaluation of dengue vaccines in exposed populations, because Phase 1 and 2 clinical trials of dengue vaccines have begun, and Phase 3 field trials may be warranted soon. In response ...

Mar 10th, 2023 - Study Description: Phase 1 trial wherein healthy adults with no (naive), one (primary heterotypic), or more than one (polytypic) previous natural dengue virus (DENV) infection(s) will be immunized with the DENV3 monovalent vaccine rDEN3delta30/31-...

Mar 9th, 2023 - The purpose of this research study is to test a weakened form of an experimental dengue virus challenge at different doses to test if participants develop symptoms or circulating virus in the blood (called viremia). When volunteers are exposed to ...

Mar 2nd, 2023 - The purpose of this study is to demonstrate that V181 is safe and well tolerated and elicits an immune response that is non-inferior to that of Butantan-DV at Day 28 post-vaccination in adults 18 to 50 years of age in Brazil. The primary hypothesi...

Feb 24th, 2023 - Study Design Introduction:This will be a parallel design cluster randomized controlled trial with 3 years (3 seasons) of follow-up from initial deployment of mosquitoes. The intervention will be routine control measures, as recommended by the Braz...

Feb 21st, 2023 - This is a Phase 1, open label, single center, dose escalation study to evaluate the safety, tolerability and pharmacokinetic profile of dMAb-ZK190 following delivery of INO-A002 with Hylenex® recombinant delivered IM followed by EP in healthy adul...

Vectorborne diseases are major causes of death and illness worldwide. In the United States, the most common vectorborne pathogens are transmitted by ticks or mosquitoes, including those causing Lyme disease; Rocky Mountain spotted fever; and West ...

Dec 12th, 2022 - LONDON (Reuters) - A dengue vaccine developed by Japanese drugmaker Takeda Pharmaceutical Co was authorised for use in the European Union on Thursday, making it the second approved inoculation against the mosquito-borne disease that causes million...

Dengue is spread through Aedes aegypti and Aedes albopictus mosquito bites, found throughout the tropical and subtropical regions of the world. Learn more about these aggressive daytime biters and this disease.

Oct 21st, 2022 - As of Sept. 20, 2022, 47 autochthonous cases of dengue fever, spread across five clusters, have been reported in mainland France since July. These figures mark an increase in autochthonous transmission on several levels. A record number of cases h...

Oct 20th, 2022 - The CDC's Advisory Committee on Immunization Practices (ACIP) voted unanimously Thursday to add COVID-19 vaccination to its panel of routine immunizations for both kids and adults. The 15-0 vote does not mandate vaccination for children or adults ...